By Mill Chart
Last update: Jun 20, 2025
GILEAD SCIENCES INC (NASDAQ:GILD) was identified through our Caviar Cruise quality investing screen, which focuses on companies with strong fundamentals, profitability, and financial health. GILD stands out for its high return on capital, solid cash flow generation, and reasonable valuation, making it a candidate for long-term investors. Below, we examine why this biopharmaceutical firm fits the criteria for quality investing.
Our report assigns GILD a fundamental rating of 6/10, highlighting its profitability and value characteristics. Key takeaways:
For investors seeking quality stocks with a mix of profitability, cash flow strength, and reasonable valuation, GILD presents a compelling case.
Our Caviar Cruise screener lists more quality stocks and is updated regularly.
This is not investing advice. Always conduct your own research before making investment decisions.
NASDAQ:GILD (7/11/2025, 3:37:07 PM)
110.1
-4.44 (-3.88%)
Find more stocks in the Stock Screener
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
GILEAD SCIENCES INC (NASDAQ:GILD) shows strong technicals and a high-quality breakout setup, making it a stock to watch for momentum traders.